Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
4
36%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
N/A4 (66.7%)

Trials by Status

unknown218%
active_not_recruiting19%
completed873%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11